JP Patent
JP6002825B2 — 増殖性疾患の治療のための大環状誘導体
Assigned to ファイザー・インク · Expires 2016-10-05 · 10y expired
What this patent protects
Patent listed against Lorbrena.
Drugs covered by this patent
- Lorbrena (lorlatinib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.